SMCHD1 Pathways as Candidate Targets for FSHD

SMCHD1 通路作为 FSHD 的候选目标

基本信息

  • 批准号:
    10674006
  • 负责人:
  • 金额:
    $ 43.02万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-04-25 至 2025-06-30
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY Facioscapulohumeral dystrophy (FSHD) affects ~1/10,000 people and is caused by decreased epigenetic repression of the DUX4 retrogene with subsequent mis-expression of DUX4 in skeletal muscle. As increasing the SMCHD1-mediated epigenetic repression at the D4Z4 locus silences DUX4 in FSHD1 and FSHD2 muscle cells, this application will take a direct molecular biology approach to identify the diversity of SMCHD1 complexes and the role of each component in establishing and maintaining repressive chromatin structure at the D4Z4 and preventing DUX4 expression in skeletal muscle. The broad and long-term goal is to determine the functional components of the SMCHD1 complexes at the D4Z4 locus as a basis for future therapies directed at increasing epigenetic repression. The major hypothesis is that SMCHD1 forms different interactions depending on post- translational modification, chromatin association, and developmental state of the cell, and that understanding the functional roles of the different complexes will provide simple reductionist models for testing candidate interventions. Aim 1 will determine the proteins complexed with SMCHD1 at the D4Z4 locus and their functional significance, chromatin association, and SUMO dependence. Aim 2 will determine the composition of SMCHD1 complexes at autosomal single copy loci in the genome compared to repetitive regions and to subdomains of the D4Z4. Aim 3 will identify the relative roles of SMCHD1 complex components in the establishment and maintenance of epigenetic modifications during stem cell reprogramming and differentiation. Together, these aims will add clarity to the components of SMCHD1 complexes and their functional roles in D4Z4 epigenetic repression, and provide new opportunities to design interventions to suppress DUX4 expression as a treatment for FSHD.
项目总结

项目成果

期刊论文数量(12)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The prospects of targeting DUX4 in facioscapulohumeral muscular dystrophy.
  • DOI:
    10.1097/wco.0000000000000849
  • 发表时间:
    2020-10
  • 期刊:
  • 影响因子:
    4.8
  • 作者:
    Bouwman LF;van der Maarel SM;de Greef JC
  • 通讯作者:
    de Greef JC
A proteomics study identifying interactors of the FSHD2 gene product SMCHD1 reveals RUVBL1-dependent DUX4 repression.
  • DOI:
    10.1038/s41598-021-03030-3
  • 发表时间:
    2021-12-08
  • 期刊:
  • 影响因子:
    4.6
  • 作者:
    Goossens R;Tihaya MS;van den Heuvel A;Tabot-Ndip K;Willemsen IM;Tapscott SJ;González-Prieto R;Chang JG;Vertegaal ACO;Balog J;van der Maarel SM
  • 通讯作者:
    van der Maarel SM
Small noncoding RNAs in FSHD2 muscle cells reveal both DUX4- and SMCHD1-specific signatures.
FSHD2 肌肉细胞中的小非编码 RNA 揭示了 DUX4 和 SMCHD1 特异性特征。
  • DOI:
    10.1093/hmg/ddy173
  • 发表时间:
    2018
  • 期刊:
  • 影响因子:
    3.5
  • 作者:
    Lim,Jong-Won;Wong,Chao-Jen;Yao,Zizhen;Tawil,Rabi;vanderMaarel,SilvèreM;Miller,DanielG;Tapscott,StephenJ;Filippova,GalinaN
  • 通讯作者:
    Filippova,GalinaN
SMCHD1 has separable roles in chromatin architecture and gene silencing that could be targeted in disease.
  • DOI:
    10.1038/s41467-023-40992-6
  • 发表时间:
    2023-09-25
  • 期刊:
  • 影响因子:
    16.6
  • 作者:
    Tapia del Fierro, Andres;den Hamer, Bianca;Benetti, Natalia;Jansz, Natasha;Chen, Kelan;Beck, Tamara;Vanyai, Hannah;Gurzau, Alexandra D.;Daxinger, Lucia;Xue, Shifeng;Ly, Thanh Thao Nguyen;Wanigasuriya, Iromi;Iminitoff, Megan;Breslin, Kelsey;Oey, Harald;Krom, Yvonne D.;van der Hoorn, Dinja;Bouwman, Linde F.;Johanson, Timothy M.;Ritchie, Matthew E.;Gouil, Quentin A.;Reversade, Bruno;Prin, Fabrice;Mohun, Timothy;van der Maarel, Silvere M.;Mcglinn, Edwina;Murphy, James M.;Keniry, Andrew;de Greef, Jessica C.;Blewitt, Marnie E.
  • 通讯作者:
    Blewitt, Marnie E.
Dnmt3b regulates DUX4 expression in a tissue-dependent manner in transgenic D4Z4 mice.
  • DOI:
    10.1186/s13395-020-00247-0
  • 发表时间:
    2020-10-01
  • 期刊:
  • 影响因子:
    4.9
  • 作者:
    Bouwman LF;den Hamer B;Verveer EP;Lerink LJS;Krom YD;van der Maarel SM;de Greef JC
  • 通讯作者:
    de Greef JC
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Stephen J Tapscott其他文献

Stephen J Tapscott的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Stephen J Tapscott', 18)}}的其他基金

The pathogenesis of facioscapulohumeral muscular dystrophy
面肩肱型肌营养不良症的发病机制
  • 批准号:
    9767865
  • 财政年份:
    2015
  • 资助金额:
    $ 43.02万
  • 项目类别:
The pathogenesis of facioscapulohumeral muscular dystrophy
面肩肱型肌营养不良症的发病机制
  • 批准号:
    8998512
  • 财政年份:
    2015
  • 资助金额:
    $ 43.02万
  • 项目类别:
SMCHD1 Pathways as Candidate Targets for FSHD
SMCHD1 通路作为 FSHD 的候选目标
  • 批准号:
    9235242
  • 财政年份:
    2014
  • 资助金额:
    $ 43.02万
  • 项目类别:
Facioscapulohumeral dystrophy clinical trial foundations
面肩肱营养不良临床试验基础
  • 批准号:
    10712153
  • 财政年份:
    2014
  • 资助金额:
    $ 43.02万
  • 项目类别:
SMCHD1 pathways as candidate targets for FSHD
SMCHD1 通路作为 FSHD 的候选靶点
  • 批准号:
    8841678
  • 财政年份:
    2014
  • 资助金额:
    $ 43.02万
  • 项目类别:
SMCHD1 Pathways as Candidate Targets for FSHD
SMCHD1 通路作为 FSHD 的候选目标
  • 批准号:
    10438685
  • 财政年份:
    2014
  • 资助金额:
    $ 43.02万
  • 项目类别:
SMCHD1 pathways as candidate targets for FSHD
SMCHD1 通路作为 FSHD 的候选靶点
  • 批准号:
    8687333
  • 财政年份:
    2014
  • 资助金额:
    $ 43.02万
  • 项目类别:
SMCHD1 Pathways as Candidate Targets for FSHD
SMCHD1 通路作为 FSHD 的候选目标
  • 批准号:
    10055585
  • 财政年份:
    2014
  • 资助金额:
    $ 43.02万
  • 项目类别:
RNA in Regulation
RNA 的调控
  • 批准号:
    9042624
  • 财政年份:
    2014
  • 资助金额:
    $ 43.02万
  • 项目类别:
SMCHD1 Pathways as Candidate Targets for FSHD
SMCHD1 通路作为 FSHD 的候选目标
  • 批准号:
    10662214
  • 财政年份:
    2014
  • 资助金额:
    $ 43.02万
  • 项目类别:

相似国自然基金

帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
  • 批准号:
    32170319
  • 批准年份:
    2021
  • 资助金额:
    58.00 万元
  • 项目类别:
    面上项目
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
  • 批准号:
  • 批准年份:
    2021
  • 资助金额:
    58 万元
  • 项目类别:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
  • 批准号:
    31672538
  • 批准年份:
    2016
  • 资助金额:
    62.0 万元
  • 项目类别:
    面上项目
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
  • 批准号:
    31372080
  • 批准年份:
    2013
  • 资助金额:
    80.0 万元
  • 项目类别:
    面上项目
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
  • 批准号:
    81172529
  • 批准年份:
    2011
  • 资助金额:
    58.0 万元
  • 项目类别:
    面上项目
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
  • 批准号:
    81070952
  • 批准年份:
    2010
  • 资助金额:
    35.0 万元
  • 项目类别:
    面上项目
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
  • 批准号:
    30672361
  • 批准年份:
    2006
  • 资助金额:
    24.0 万元
  • 项目类别:
    面上项目

相似海外基金

Bridging the Gap: Next-Gen Tools for Accurate Prediction of Disordered Protein Binding Sites
弥合差距:准确预测无序蛋白质结合位点的下一代工具
  • 批准号:
    24K15172
  • 财政年份:
    2024
  • 资助金额:
    $ 43.02万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Design of protein crystal templates with multiple binding sites for tracking metal complex reactions.
设计具有多个结合位点的蛋白质晶体模板,用于跟踪金属络合物反应。
  • 批准号:
    23K04928
  • 财政年份:
    2023
  • 资助金额:
    $ 43.02万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Dynamic changes in PIP2 binding sites and their impact on axonal targeting and function of epilepsy-associated KCNQ/Kv7 channels
PIP2 结合位点的动态变化及其对癫痫相关 KCNQ/Kv7 通道的轴突靶向和功能的影响
  • 批准号:
    10744934
  • 财政年份:
    2023
  • 资助金额:
    $ 43.02万
  • 项目类别:
Computational methods to identify small molecule RNA binding sites
识别小分子 RNA 结合位点的计算方法
  • 批准号:
    573688-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 43.02万
  • 项目类别:
    University Undergraduate Student Research Awards
Identification of potential drug binding sites within allosteric networks in cyclic nucleotide modulated channels
环核苷酸调节通道变构网络内潜在药物结合位点的鉴定
  • 批准号:
    10704557
  • 财政年份:
    2022
  • 资助金额:
    $ 43.02万
  • 项目类别:
Identification of potential drug binding sites within allosteric networks in cyclic nucleotide modulated channels
环核苷酸调节通道变构网络内潜在药物结合位点的鉴定
  • 批准号:
    10537846
  • 财政年份:
    2022
  • 资助金额:
    $ 43.02万
  • 项目类别:
Identifying new types of inhibitors in quinone binding sites in photosynthetic enzymes
鉴定光合酶醌结合位点的新型抑制剂
  • 批准号:
    2753921
  • 财政年份:
    2022
  • 资助金额:
    $ 43.02万
  • 项目类别:
    Studentship
Development of broad nanovaccines targeting diverse coronavirus receptor-binding sites
开发针对不同冠状病毒受体结合位点的广泛纳米疫苗
  • 批准号:
    10328140
  • 财政年份:
    2022
  • 资助金额:
    $ 43.02万
  • 项目类别:
Exploiting Water Network Perturbations in Protein Binding Sites
利用蛋白质结合位点的水网络扰动
  • 批准号:
    10621368
  • 财政年份:
    2021
  • 资助金额:
    $ 43.02万
  • 项目类别:
SBIR Phase I: Nonlinear optical method for identifying protein-ligand binding sites
SBIR 第一阶段:识别蛋白质-配体结合位点的非线性光学方法
  • 批准号:
    2111821
  • 财政年份:
    2021
  • 资助金额:
    $ 43.02万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了